A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes
E. J. Rhee, W. Y. Lee, K. H. Yoon, S. J. Yoo, I. K. Lee, S. H. Baik, Y. K. Kim, M. K. Lee, K. S. Park, J. Y. Park, B. S. Cha, H. W. Lee, K. W. Min, H. Y. Bae, M. J. Kim, J. A. Kim, D. K. Kim, Sun Woo Kim
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes'. Together they form a unique fingerprint.